Spain· ES:61225
IOPIMAX 10 mg/ml COLIRIO EN SOLUCION
A medicinal product containing apraclonidina, registered in Spain by Essential Pharma Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- apraclonidina
- Manufacturer
- Essential Pharma Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Apraclonidina in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomApraclonidine 1% eye drops 0.25ml unit dose preservative freeEssential Pharma Ltd
- NetherlandsIopidine 1,0% 10 mg/ml, oogdruppels, oplossingEssential Pharma (M) Limited
- SwitzerlandIopidine
- FranceIOPIDINE 0,5 %, collyre en solutionESSENTIAL PHARMA (M) (MALTE)
- United StatesApraclonidineSandoz Inc
- CanadaIOPIDINEESSENTIAL PHARMA SWITZERLAND GMBH
- FinlandIopidineEssential Pharma Ltd
- IrelandIOPIDINE 1%w/v Eye Drops, SolutionEssential Pharma Limited
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Iopidine
- Belgium · Iopidine
- Germany · Iopidine®
- Denmark · Iopidine
- Finland · Iopidine
- France · Iopidine
- United Kingdom (Northern Ireland) · Apraclonidine, Apraclonidine Essential Pharma
- Greece · Iopidine
- Ireland · Iopidine
- Italy · Iopidine
- Luxembourg · Iopidine
- Malta · Iopidine
- Netherlands · Iopidine
- Norway · Iopidine
- Portugal · Iopidine
- Sweden · Iopidine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ebdab5a6-83f0-4a75-9c7b-3e54d2953f5f GET /v1/drugs/ebdab5a6-83f0-4a75-9c7b-3e54d2953f5f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":867708000000}",
"nregistro": "61225",
"substance": "apraclonidina"
}See everything about apraclonidina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.